Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
41 studies found for:    Open Studies | "Papilloma"
Show Display Options
Rank Status Study
21 Recruiting Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer
Conditions: Human Papilloma Virus Infection;   Stage III Squamous Cell Carcinoma of the Oropharynx;   Stage IVA Squamous Cell Carcinoma of the Oropharynx;   Stage IVB Squamous Cell Carcinoma of the Oropharynx
Interventions: Procedure: therapeutic conventional surgery;   Radiation: intensity-modulated radiation therapy;   Drug: cisplatin;   Drug: carboplatin;   Other: laboratory biomarker analysis;   Other: quality-of-life assessment
22 Recruiting Image-Guided Stereotactic Radiosurgery (SRS) Boost for HPV-Oropharyngeal Cancer
Condition: Cancer of the Oropharynx
Intervention: Radiation: Stereotactic Radiosurgery
23 Recruiting CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
Conditions: Atypical Endocervical Glandular Cell of Undetermined Significance;   Atypical Endometrial Hyperplasia;   Human Papillomavirus Infection;   Stage 0 Cervical Cancer
Interventions: Other: Cytology Specimen Collection Procedure;   Other: Laboratory Biomarker Analysis
24 Recruiting Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer
Conditions: Human Papillomavirus Infection;   Stage I Oral Cavity Squamous Cell Carcinoma;   Stage I Oropharyngeal Squamous Cell Carcinoma;   Stage II Oral Cavity Squamous Cell Carcinoma;   Stage II Oropharyngeal Squamous Cell Carcinoma;   Stage III Oral Cavity Squamous Cell Carcinoma;   Stage III Oropharyngeal Squamous Cell Carcinoma;   Stage IVA Oral Cavity Squamous Cell Carcinoma;   Stage IVA Oropharyngeal Squamous Cell Carcinoma;   Stage IVB Oral Cavity Squamous Cell Carcinoma;   Stage IVB Oropharyngeal Squamous Cell Carcinoma;   Stage IVC Oropharyngeal Squamous Cell Carcinoma
Interventions: Biological: Durvalumab;   Other: Laboratory Biomarker Analysis;   Procedure: Therapeutic Conventional Surgery
25 Not yet recruiting Pharmacodynamic Study to Assess the Anti-proliferative Activity of the PARP Inhibitor Olaparib in Patients With HPV Positive and HPV Negative HNSCC
Condition: Squamous Cell Carcinoma of the Head and Neck
Intervention: Drug: Olaparib
26 Recruiting Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions
Conditions: Anal Cancer;   High-grade Squamous Intraepithelial Lesion;   HIV Infection;   Human Papilloma Virus Infection
Interventions: Drug: imiquimod;   Drug: fluorouracil;   Procedure: infrared photocoagulation therapy;   Procedure: thermal ablation therapy;   Procedure: laser therapy;   Other: clinical observation;   Other: laboratory biomarker analysis;   Procedure: quality-of-life assessment
27 Recruiting Study of the Therapeutic Vaccine (ISA101/ISA101b) to Treat Advanced or Recurrent Cervical Cancer
Condition: Cervical Cancer
Intervention: Drug: ISA101/ISA101b
28 Recruiting Intra-Anally Administered Artesunate in Patients With High-Grade Anal Intraepithelial Neoplasia (AIN 2/3)
Conditions: HPV-Related Anal Intraepithelial Neoplasia;   AIN2/3;   Artesunate;   Alternative Treatment;   Anal Dysplasia;   Precancerous Conditions;   Human Papilloma Virus
Intervention: Drug: Artesunate Suppositories
29 Not yet recruiting Safety Study of EF-022 in Adults With Recurrent Respiratory Papillomatosis (RRP)
Condition: Recurrent Respiratory Papillomatosis
Intervention: Drug: EF-022 (Modified Vitamin D Binding Protein Macrophage Activator)
30 Recruiting Bevacizumab Versus Cidofovir for the Treatment of Recurrent Respiratory Papillomatosis
Condition: Recurrent Respiratory Papillomatosis
Interventions: Drug: Bevacizumab;   Drug: Cidofovir;   Other: Placebo
31 Recruiting 18F FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
Conditions: Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Male Breast Cancer;   Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma;   Recurrent Adenoid Cystic Carcinoma of the Oral Cavity;   Recurrent Adult Brain Tumor;   Recurrent Basal Cell Carcinoma of the Lip;   Recurrent Breast Cancer;   Recurrent Colon Cancer;   Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity;   Recurrent Hypopharyngeal Cancer;   Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity;   Recurrent Laryngeal Cancer;   Recurrent Lip and Oral Cavity Cancer;   Recurrent Lymphoepithelioma of the Nasopharynx;   Recurrent Lymphoepithelioma of the Oropharynx;   Recurrent Metastatic Squamous Neck Cancer With Occult Primary;   Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity;   Recurrent Mucoepidermoid Carcinoma of the Oral Cavity;   Recurrent Nasopharyngeal Cancer;   Recurrent Non-small Cell Lung Cancer;   Recurrent Oropharyngeal Cancer;   Recurrent Pancreatic Cancer;   Recurrent Paranasal Sinus and Nasal Cavity Cancer;   Recurrent Rectal Cancer;   Recurrent Renal Cell Cancer;   Recurrent Salivary Gland Cancer;   Stage IIIA Breast Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Breast Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer;   Stage IV Non-small Cell Lung Cancer;   Stage IV Pancreatic Cancer;   Stage IV Renal Cell Cancer;   Stage IVA Colon Cancer;   Stage IVA Rectal Cancer;   Stage IVA Salivary Gland Cancer;   Stage IVB Colon Cancer;   Stage IVB Salivary Gland Cancer;   Stage IVC Salivary Gland Cancer;   Tongue Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: fludeoxyglucose F 18;   Drug: 2-fluoropropionyl-labeled pegylated dimeric RGD peptide;   Diagnostic Test: positron emission tomography;   Diagnostic Test: computed tomography;   Other: laboratory biomarker analysis
32 Recruiting Recurrent Respiratory Papillomatosis and Extraesophageal Reflux
Conditions: Recurrent Respiratory Papillomatosis;   Extra Oesophageal Reflux;   Laryngeal Cyst
Interventions: Procedure: Surgical collection of histology specimen;   Procedure: Performance of immunohistochemical analysis
33 Recruiting Weekly Cetuximab/RT Versus Weekly Cisplatin/RT in HPV-Associated Oropharyngeal Squamous Cell Carcinoma
Condition: HPV Positive Oropharyngeal Squamous Cell Carcinoma
Interventions: Drug: Cetuximab;   Radiation: RT (70 Gy in 35 fractions);   Drug: Cisplatin
34 Not yet recruiting An Innovative Treatment for Cervical Precancer (UH3)
Condition: Cervical Intraepithelial Neoplasia
Interventions: Device: CO2 standard therapy;   Device: CryoPen;   Device: Thermocoagulator
35 Not yet recruiting Human Papillomavirus and Cervical Dysplasia in Women With Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Procedure: Pap smear test and HPV test
36 Recruiting Human Papillomavirus (HPV) and Risk of Cervical Precancer and Cancer
Condition: Cervical Neoplasia
Intervention:
37 Not yet recruiting Phase II Treatment Stratification Trial Using Neck Dissection-Driven Selection to Improve Quality of Life for Low Risk Patients With HPV+ Oropharyngeal Squamous Cell Cancer
Condition: Oropharyngeal Squamous Cell Cancer
Interventions: Procedure: Neck Dissection;   Procedure: Transoral Surgery of Primary Site;   Radiation: Radiation;   Drug: Carboplatin;   Drug: Paclitaxel
38 Recruiting American Breast Laser Ablation Therapy Evaluation
Condition: Benign Breast Conditions; Breast Fibroadenomas
Intervention:
39 Recruiting Exploratory Study of Efficacy and Safety of Ingenol Mebutate 0.05% Gel for Common Warts on the Hands.
Conditions: Verruca Vulgaris;   Common Warts
Intervention: Drug: ingenol mebutate 0.05% gel
40 Recruiting Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma
Condition: Oropharyngeal Cancer
Interventions: Procedure: Transoral Robotic Surgery (TORS);   Procedure: Modified Barium Swallow (MBS);   Behavioral: Questionnaires

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-41) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.